JPM

Robbie Marcus

Q: How accurate are Robbie Marcus's stock ratings?

About 73% of Robbie's ratings were profitable over a one-year hold, with an average return of +10.4% per rating, measured by 13Foresight from historical prices.

Q: How is Robbie ranked?

Robbie Marcus is ranked #285 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

J.P. Morgan

Wall Street Analyst

★★★★★

#285

on 13Foresight · ranked by our own returns

73%

Success Rate

+10.7%

Average Return

43 of 59 calls profitable · +3.4% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

🔒 5-year track record is Pro. Showing 1-year — upgrade.

📈 Across the calls we could measure, roughly 73% of Robbie Marcus's ratings turned a profit when each position was held for 1 year — averaging +10.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

43 Buy 38 Hold 7 Sell

Robbie's Stock Coverage 38 ratings · 2026-08-14

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
MOBI Mobia Medical, Inc.	Aug 12, 2026	BUY	Strong Buy +77.6% avg upside 4 analysts	$17.00 45.52% Upside	·	·
KMTS Kestra Medical Technologies Ltd.	Aug 10, 2026	BUY	Strong Buy +1.8% avg upside 9 analysts	$30.00 8.17% Upside	-1.2%	·
ENOV Enovis	Aug 10, 2026	HOLD	Strong Buy +162.4% avg upside 39 analysts	$28.00 9.05% Upside	+7.5%	·
BDX Becton Dickinson	Aug 10, 2026	HOLD	Buy +7.8% avg upside 25 analysts	$188.00 3.25% Upside	+1.3%	·
BAX Baxter International	Aug 06, 2026	HOLD	Buy +23.8% avg upside 23 analysts	$26.00 3.87% Downside	+0.1%	·
RXST RxSight	Aug 06, 2026	SELL	Hold +26.8% avg upside 13 analysts	$6.00 14.48% Downside	-13.3%	·
PODD Insulet	Aug 05, 2026	HOLD	Strong Buy +48.7% avg upside 32 analysts	$152.00 3.73% Upside	+7.6%	·
SYK Stryker	Aug 04, 2026	BUY	Strong Buy +8.2% avg upside 37 analysts	$350.00 2.61% Upside	+1.5%	·
INSP Inspire Medical Systems	Aug 04, 2026	HOLD	Buy +45.8% avg upside 21 analysts	$60.00 3.05% Upside	-11.0%	·
MMSI Merit Medical Systems	Aug 04, 2026	BUY	Strong Buy +9.2% avg upside 15 analysts	$95.00 4.99% Upside	+5.6%	·
IART Integra Lifesciences	Aug 04, 2026	SELL	Buy +139.3% avg upside 21 analysts	$17.00 6.75% Downside	-1.9%	·
DXCM Dexcom	Aug 04, 2026	HOLD	Strong Buy +16.1% avg upside 32 analysts	$82.00 10.42% Downside	+3.2%	·
GEHC GE Healthcare Technologies Inc	Jul 30, 2026	HOLD	Strong Buy +11.5% avg upside 22 analysts	$70.00 5.08% Downside	+5.4%	·
CNMD Conmed	Jul 30, 2026	HOLD	Hold +30.6% avg upside 12 analysts	$45.00 9.71% Downside	+6.0%	·
BSX Boston Scientific	Jul 30, 2026	BUY	Strong Buy +31.1% avg upside 38 analysts	$56.00 8.43% Upside	+11.8%	·
EW Edwards Lifesciences	Jul 28, 2026	BUY	Strong Buy +8.5% avg upside 34 analysts	$105.00 13.34% Upside	+9.5%	·
ISRG Intuitive Surgical	Jul 21, 2026	BUY	Strong Buy +19.8% avg upside 36 analysts	$450.00 12.07% Upside	+12.7%	·
ABT Abbott Laboratories	Jul 17, 2026	BUY	Strong Buy +4.4% avg upside 36 analysts	$120.00 7.87% Upside	+7.9%	·
MDT Medtronic	Jun 05, 2026	HOLD	Buy +6.4% avg upside 38 analysts	$86.00 5.10% Downside	+13.3%	·
COO Cooper Co	Jun 05, 2026	HOLD	Buy +74.2% avg upside 21 analysts	$71.00 7.33% Downside	+13.9%	·
CVRX CVRx	May 12, 2026	SELL	Buy +155.1% avg upside 9 analysts	$6.00 104.06% Upside	+41.6%	·
ZBH Zimmer Biomet Holdings	Apr 29, 2026	HOLD	Buy +15.1% avg upside 38 analysts	$95.00 4.57% Downside	+26.0%	·
HTFL HeartFlow, Inc.	Mar 25, 2026	BUY	Strong Buy +19.8% avg upside 9 analysts	$35.00 12.88% Upside	+51.6%	·
PEN Penumbra	Dec 18, 2025	BUY	Buy +1.1% avg upside 23 analysts	$370.00 13.33% Upside	+3.7%	·
CBLL Ceribell, Inc.	Nov 05, 2025	BUY	Strong Buy +8.2% avg upside 8 analysts	$17.00 26.87% Downside	+98.0%	·
BLCO Bausch + Lomb Corporation	Oct 30, 2025	HOLD	Buy +17.5% avg upside 19 analysts	$16.00 5.75% Downside	+12.6%	·
INGN Inogen	Aug 08, 2025	SELL	Buy +324.5% avg upside 7 analysts	$7.00 20.40% Upside	+6.6%	·
BVS Bioventus	May 06, 2025	HOLD	Strong Buy -2.8% avg upside 8 analysts	$7.00 49.56% Downside	+76.1%	·
ATRC Atricure	Feb 11, 2025	BUY	Strong Buy +5.6% avg upside 13 analysts	$51.00 17.18% Upside	-20.7%	·
NPCE NeuroPace	Dec 17, 2024	BUY	Strong Buy +24.9% avg upside 13 analysts	$14.00 3.50% Downside	+35.6%	·
TMCI Treace Medical Concepts	May 08, 2024	HOLD	Hold +32.2% avg upside 8 analysts	$8.00 77.48% Upside	+80.8%	·
UTRS Minerva Surgical	Sep 06, 2022	SELL	Hold +7999900.0% avg upside 4 analysts	—	·	·
AFIB Acutus Medical	Nov 18, 2021	SELL	Sell +619900.1% avg upside 5 analysts	—	·	·
SDCCQ SmileDirectClub	Aug 10, 2021	SELL	Sell +114399900.0% avg upside 10 analysts	$6.00 59999899.99% Upside	·	·
GKOS Glaukos	May 06, 2021	SELL	Strong Buy -10.8% avg upside 21 analysts	$85.00 55.04% Downside	+50.0%	·
IRTC Irhythm Technologies	Apr 12, 2021	HOLD	Strong Buy +35.2% avg upside 20 analysts	$95.00 22.82% Downside	+84.1%	·
TMDX TransMedics Group	May 28, 2019	BUY	Strong Buy +14.7% avg upside 15 analysts	$34.00 62.04% Downside	-54.1%	·
PENN PENN Entertainment	Jun 08, 2018	BUY	Strong Buy +60.5% avg upside 32 analysts	$40.00 112.25% Upside	-39.1%	·

🔒 33 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Robbie Marcus — Frequently Asked Questions

How accurate are Robbie Marcus's stock ratings?

Based on the calls 13Foresight could measure, about 73% of Robbie's ratings were profitable over a one-year hold, with an average return of +10.4% per rating, or +3.4% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Robbie ranked on 13Foresight?

Robbie Marcus is currently ranked #285 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Robbie cover?

Robbie most recently has ratings on MOBI, KMTS, ENOV, BDX, BAX, RXST, PODD, SYK, INSP, MMSI, IART, DXCM and 26 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Robbie Marcus

Rating Distribution

Welcome to 13Foresight!